Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus-Reference-Cited by-同舟云学术

Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus

Published:2016-07-15 Issue:4 Volume:10 Page:617-623
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Tamai Hideyuki¹,Shingaki Naoki¹,Mori Yoshiyuki¹,Moribata Kosaku¹,Kawashima Akira²,Maeda Yoshimasa¹,Niwa Toru¹,Deguchi Hisanobu¹,Inoue Izumi¹,Maekita Takao¹,Iguchi Mikitaka¹,Kato Jun¹,Ichinose Masao¹

Affiliation:

1. Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan

2. Department of Internal Medicine, Naga Municipal Hospital, Wakayama, Japan

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2016/010/gnl-10-617.pdf

Reference26 articles.

1. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

2. Guidelines for the Management of Hepatitis C Virus Infection

3. Outcome of sustained virological responders with histologically advanced chronic hepatitis C

4. Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C

5. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic review

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Evidence on the Use of Hyaluronic Acid as Nonsurgical Option for the Treatment of Peyronie’s Disease: A Contemporary Review;Uro;2023-06-01

2. Purification and mass spectrometry study of Maillard reaction impurities in five acyclic nucleoside antiviral drugs;Journal of Pharmaceutical and Biomedical Analysis;2022-04

3. NON-SURGICAL TREATMENT OF PEYRONIE’S DISEASE: A COMPREHENSIVE REVIEW;Wiadomości Lekarskie;2021

4. Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over;World Journal of Hepatology;2020-09-27

5. Peginterferon α 2b /ribavirin;Reactions Weekly;2017-07